What top creators are saying about Tango Therapeutics(TNGX)

A biotechnology company focused on developing cancer therapies.

2 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Tango Therapeutics in the last 30 days yet.

Top creators covering Tango Therapeutics (TNGX)

The 1 sources with the most insights about Tango Therapeutics on Kazuha.

Latest insights about Tango Therapeutics (TNGX)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Sunday, September 14, 2025

Very Bearish

A major 10% owner sold $5.11 million worth of stock. Historically, the stock has fallen an average of 42% in the three months following this specific owner's sales, creating a very strong warning signal.

Wednesday, September 10, 2025

Very Bearish

A 10% owner made an unscheduled sale, and this insider's previous sales have been followed by an average stock decline of over 40% within three months, a very strong bearish signal.

Discussed alongside Tango Therapeutics (TNGX)

Other assets that creators frequently mention in the same content as Tango Therapeutics.

Frequently asked

Which podcasters and creators cover Tango Therapeutics (TNGX) the most?

The most active sources covering Tango Therapeutics (TNGX) on Kazuha are @ceowatcher. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Tango Therapeutics (TNGX) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Tango Therapeutics (TNGX) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Tango Therapeutics (TNGX)?

Creators covering Tango Therapeutics (TNGX) most frequently also discuss CECE, MDU, ESTC, DHI, VRT. See the "Discussed alongside" section above for full asset pages.